Paricalcitol

( DrugBank: Paricalcitol / KEGG DRUG: Paricalcitol )


5 diseases
IDDisease name (Link within this page)Number of trials
19Lysosomal storage disease1
66IgA nephropathy1
218Alport syndrome1
IDDisease name (Link within this page)Number of trials
238Vitamin D-resistant rickets1
298Hereditary pancreatitis1

19. Lysosomal storage disease


Clinical trials : 990Drugs : 584 - (DrugBank : 126) / Drug target genes : 62 - Drug target pathways : 192 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

66. IgA nephropathy


Clinical trials : 349Drugs : 251 - (DrugBank : 75) / Drug target genes : 43 - Drug target pathways : 152 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

218. Alport syndrome


Clinical trials : 41Drugs : 32 - (DrugBank : 19) / Drug target genes : 8 - Drug target pathways : 44 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

238. Vitamin D-resistant rickets


Clinical trials : 32Drugs : 20 - (DrugBank : 11) / Drug target genes : 5 - Drug target pathways : 23 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

298. Hereditary pancreatitis


Clinical trials : 110Drugs : 142 - (DrugBank : 59) / Drug target genes : 61 - Drug target pathways : 154 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries